STOCK TITAN

UFP Technologies Inc. - UFPT STOCK NEWS

Welcome to our dedicated news page for UFP Technologies (Ticker: UFPT), a resource for investors and traders seeking the latest updates and insights on UFP Technologies.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect UFP Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of UFP Technologies's position in the market.

Rhea-AI Summary
UFP Technologies, Inc. (UFPT) announced participation in KeyBanc Capital Markets 4th Annual Life Sciences and MedTech Investor Forum. Chairman R. Jeffrey Bailly and CFO Ron Lataille will present virtually on March 20, 2024, at 9:45 AM ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.58%
Tags
conferences
-
Rhea-AI Summary
UFP Technologies, Inc. (UFPT) reports impressive financial results for the year 2023, with a net income of $44.9 million and net sales of $400.1 million, marking a 13.1% increase from the previous year. The company also saw growth in the fourth quarter, with net income of $11.6 million and sales of $101.5 million, showcasing a positive outlook for future expansion and acquisitions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.45%
Tags
none
-
Rhea-AI Summary
UFP Technologies, Inc. announces the appointment of Mitchell Rock as President of the Company. Rock has been serving as President of the Company’s MedTech business. R. Jeffrey Bailly will continue in his capacity as Chairman and Chief Executive Officer. The Company is an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market. UFP Technologies is a key link in the medical device supply chain and a valued outsource partner to many top medical device manufacturers worldwide. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for various medical applications.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.08%
Tags
none
Rhea-AI Summary
UFP Technologies, Inc. (Nasdaq: UFPT) announced that Chairman and CEO R. Jeffrey Bailly and CFO Ron Lataille will participate in the CJS Securities 24th Annual 'New Ideas for the New Year' Conference on January 10, 2024. The presentation is set to begin at 11:45 AM ET. UFP Technologies is an innovative designer and custom manufacturer primarily for the medical market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
conferences
-
Rhea-AI Summary
UFP Technologies, Inc. (UFPT) to participate in Piper Sandler 35th Annual Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
conferences
-
Rhea-AI Summary
UFP Technologies, Inc. (Nasdaq: UFPT) reported a 13.8% increase in adjusted net income to $11.9 million in Q3 2023 compared to Q3 2022. Sales for Q3 were $100.8 million, up from $97.0 million in Q3 2022. For the nine-month period ended September 30, 2023, adjusted net income increased 44.4% to $35.8 million, with sales of $298.6 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.35%
Tags
earnings
Rhea-AI Summary
UFP Technologies to participate in Midwest IDEAS Investor Conference on August 23, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
conferences
-
Rhea-AI Summary
UFP Technologies, Inc. (Nasdaq: UFPT) Reports Strong Q2 2023 Results with Net Income of $11.9M and Sales of $100M. The company's Q2 sales increased by 6.0%, with a significant 15.9% growth in sales to the medical market. Gross margin improved to 29.6% from 25.8% last year, driving a 40% increase in operating income. The company also highlighted the outperformance of its recently acquired businesses and strategic acquisition opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.24%
Tags
conferences
Rhea-AI Summary
UFP Technologies, Inc. reports strong Q1 results with net income of $9.7 million, a 98.4% increase from last year. Sales grew 37.2% to $97.8 million, driven by a 59.5% increase in MedTech business. Gross margin increased to 29.4% and operating income increased 101.9%. The company is optimistic about future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.28%
Tags
none
UFP Technologies Inc.

Nasdaq:UFPT

UFPT Rankings

UFPT Stock Data

1.93B
7.22M
6.76%
94.47%
3.18%
Corrugated and Solid Fiber Box Manufacturing
Manufacturing
Link
US
Newburyport

About UFPT

ufp technologies is a producer of innovative custom-engineered components, products, and specialty packaging. founded in 1963 and headquartered in newburyport, massachusetts, our company has pioneered a long list of processes and applications, has a large portfolio of active patents, and holds proprietary positions on many advanced materials from leading global suppliers. with a deep and accomplished engineering team, ufp technologies is a critical link in the value chain between raw material suppliers and oems. our team acts as an extension of customers'​ in-house research, engineering and manufacturing groups, working closely with them to solve their most complex product and packaging challenges. using foams, plastics, composites, and natural fiber materials, we design and manufacture a vast range of solutions primarily for six target markets including medical, automotive, aerospace & defense, electronics, consumer and industrial.